Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ecSeq Bioinformatics
    Senior Member
    • May 2012
    • 496

    #1

    Transferring patient's genetic testing data to the cloud: 5 myths

    Full article

    We often get the question: how safe is it to transfer patient’s genomic data to the cloud? By this most people refer to the transfer of their NGS-based patient data to external web-based services (e.g. Illumina Basespace) that run on the public cloud of other third-party providers (e.g. Amazon AWS).

    Of course, patient genetic data security should be a top priority. New sequencing technologies create large data volumes for each patient, and often small labs and hospitals assume that they cannot cope with the required increase in computational resources, leaving the cloud the only option. After all, cloud-based solutions are good for cases where varying amounts of data must be processed flexibly. But it is also true that a patient’s genetic testing data has a different privacy value compared to for example videos, music, images or other large data. Genetic testing data contains highly personal information, including health, behavioural and biometric information, and is an even more unique marker than a fingerprint. A DNA data breach is much worse than a credit card breach.

    With that in mind, let us address the following misconceptions and myths we often hear. ...read more

    Last edited by ecSeq Bioinformatics; 03-03-2020, 10:44 PM.
    ecSeq Bioinformatics is Europe’s leading provider of hands-on bioinformatics workshops and professional data analysis in the field of Next-Generation Sequencing (NGS).
  • LarsB
    Member
    • Feb 2013
    • 14

    #2
    Great article! Thanks!

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      Yesterday, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 05:39 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 09-29-2026, 09:51 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...